[go: up one dir, main page]

NO20070377L - Progesteron reseptor antagonist befruktningshindrende regimer og sett. - Google Patents

Progesteron reseptor antagonist befruktningshindrende regimer og sett.

Info

Publication number
NO20070377L
NO20070377L NO20070377A NO20070377A NO20070377L NO 20070377 L NO20070377 L NO 20070377L NO 20070377 A NO20070377 A NO 20070377A NO 20070377 A NO20070377 A NO 20070377A NO 20070377 L NO20070377 L NO 20070377L
Authority
NO
Norway
Prior art keywords
sets
receptor antagonist
progesterone receptor
fertilization
regimens
Prior art date
Application number
NO20070377A
Other languages
English (en)
Norwegian (no)
Inventor
Andrew Fensome
Gary Grubb
Casey Cameron Mccomas
Ginger Dale Constantine
Edward George Melenski
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35106665&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20070377(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20070377L publication Critical patent/NO20070377L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/537—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines spiro-condensed or forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20070377A 2004-07-07 2007-01-19 Progesteron reseptor antagonist befruktningshindrende regimer og sett. NO20070377L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58588304P 2004-07-07 2004-07-07
US67613505P 2005-04-29 2005-04-29
PCT/US2005/023798 WO2006017075A1 (fr) 2004-07-07 2005-07-06 Regimes et kits contraceptifs d'antagoniste de recepteur de progesterone

Publications (1)

Publication Number Publication Date
NO20070377L true NO20070377L (no) 2007-02-07

Family

ID=35106665

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070377A NO20070377L (no) 2004-07-07 2007-01-19 Progesteron reseptor antagonist befruktningshindrende regimer og sett.

Country Status (20)

Country Link
US (1) US20060009509A1 (fr)
EP (1) EP1773323A1 (fr)
JP (1) JP2008505906A (fr)
KR (1) KR20070039912A (fr)
AR (1) AR049664A1 (fr)
AU (1) AU2005271974A1 (fr)
BR (1) BRPI0512993A (fr)
CA (1) CA2571198A1 (fr)
CR (1) CR8800A (fr)
EC (1) ECSP077131A (fr)
GT (1) GT200500186A (fr)
IL (1) IL180238A0 (fr)
MX (1) MXPA06014580A (fr)
NO (1) NO20070377L (fr)
PA (1) PA8638501A1 (fr)
PE (1) PE20060485A1 (fr)
RU (1) RU2006144069A (fr)
SV (1) SV2006002166A (fr)
TW (1) TW200605880A (fr)
WO (1) WO2006017075A1 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407101B1 (en) * 1999-05-04 2002-06-18 American Home Products Corporation Cyanopyrroles
US6391907B1 (en) 1999-05-04 2002-05-21 American Home Products Corporation Indoline derivatives
US6509334B1 (en) * 1999-05-04 2003-01-21 American Home Products Corporation Cyclocarbamate derivatives as progesterone receptor modulators
UA73119C2 (en) * 2000-04-19 2005-06-15 American Home Products Corpoir Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors
GB0121285D0 (en) * 2001-09-03 2001-10-24 Cancer Res Ventures Ltd Anti-cancer combinations
PE20060378A1 (es) 2004-07-07 2006-06-02 Wyeth Corp Regimenes y kits de progestina ciclica
NZ552720A (en) 2004-07-09 2010-02-26 Population Council Inc Sustained release compositions containing progesterone receptor modulators
GT200500185A (es) * 2004-08-09 2006-04-10 Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos
AR053710A1 (es) 2005-04-11 2007-05-16 Xenon Pharmaceuticals Inc Compuestos espiroheterociclicos y sus usos como agentes terapeuticos
MY158766A (en) 2005-04-11 2016-11-15 Xenon Pharmaceuticals Inc Spiro-oxindole compounds and their uses as therapeutic agents
CA2665698A1 (fr) 2006-10-12 2008-05-22 Xenon Pharmaceuticals Inc. Utilisation de composes de spiro-oxindole comme agents therapeutiques
EP2350091B1 (fr) 2008-10-17 2015-06-03 Xenon Pharmaceuticals Inc. Composés spiro-oxindole et leur utilisation comme agents thérapeutiques
SG10201703086VA (en) 2008-10-17 2017-05-30 Xenon Pharmaceuticals Inc Spiro-oxindole compounds and their use as therapeutic agents
AU2010237120B8 (en) 2009-04-14 2015-11-26 Laboratoire Hra-Pharma Method for on-demand contraception
DK2443092T3 (en) 2009-06-18 2015-04-27 Pfizer Bicyclic and tricyclic compounds as CAT-II inhibitors
AR077252A1 (es) 2009-06-29 2011-08-10 Xenon Pharmaceuticals Inc Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos
JP5752136B2 (ja) 2009-10-14 2015-07-22 ゼノン・ファーマシューティカルズ・インコーポレイテッドＸｅｎｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． スピロ−オキシインドール化合物のための合成方法
CN105726531A (zh) 2010-02-26 2016-07-06 泽农医药公司 用于局部给药的螺-羟吲哚化合物的药物组合物及其作为治疗剂的用途
US9375437B2 (en) * 2010-06-18 2016-06-28 Lipocine Inc. Progesterone containing oral dosage forms and kits
EP2646443B1 (fr) 2010-12-01 2014-09-24 Pfizer Inc Inhibiteur de kat ii
US8951996B2 (en) 2011-07-28 2015-02-10 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
KR20150139534A (ko) 2013-03-14 2015-12-11 라보라토이레 에이치알에이 파르마 배란 일정 조정 방법
TW201636017A (zh) 2015-02-05 2016-10-16 梯瓦製藥國際有限責任公司 以螺吲哚酮化合物之局部調配物治療帶狀疱疹後遺神經痛之方法
ES3005883T3 (en) 2015-06-22 2025-03-17 Lipocine Inc 17-hydroxyprogesterone ester-containing oral compositions and related methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407101B1 (en) * 1999-05-04 2002-06-18 American Home Products Corporation Cyanopyrroles
US6444668B1 (en) * 1999-05-04 2002-09-03 Wyeth Combination regimens using progesterone receptor modulators
US6391907B1 (en) * 1999-05-04 2002-05-21 American Home Products Corporation Indoline derivatives
US6509334B1 (en) * 1999-05-04 2003-01-21 American Home Products Corporation Cyclocarbamate derivatives as progesterone receptor modulators
UA73119C2 (en) * 2000-04-19 2005-06-15 American Home Products Corpoir Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors

Also Published As

Publication number Publication date
AR049664A1 (es) 2006-08-23
PE20060485A1 (es) 2006-06-24
GT200500186A (es) 2006-03-02
EP1773323A1 (fr) 2007-04-18
MXPA06014580A (es) 2007-03-23
JP2008505906A (ja) 2008-02-28
IL180238A0 (en) 2007-07-04
SV2006002166A (es) 2006-05-09
BRPI0512993A (pt) 2008-04-22
WO2006017075A1 (fr) 2006-02-16
CA2571198A1 (fr) 2006-02-16
TW200605880A (en) 2006-02-16
ECSP077131A (es) 2007-02-28
KR20070039912A (ko) 2007-04-13
RU2006144069A (ru) 2008-08-20
AU2005271974A1 (en) 2006-02-16
US20060009509A1 (en) 2006-01-12
CR8800A (es) 2007-08-28
PA8638501A1 (es) 2006-07-03

Similar Documents

Publication Publication Date Title
NO20070377L (no) Progesteron reseptor antagonist befruktningshindrende regimer og sett.
TW200603813A (en) Cyclic progestin regimens and kits
NO20062945L (no) Forlenget anvendelseskombinasjon omfattende ostrogener og progestiner
NO20076319L (no) Farmasoytiske sammensetninger av et neuroaktivt steroid og anvendelse derav
TR200100063T2 (tr) Androst-5-en-3ß,17ß-diol için farmasötik kompozisyonlar ve kullanımlar
NO20065499L (no) Kontroll av gjennombruddsblodning i utvidede hormonelle svangerskapsforebyggende regimer
PT2061561E (pt) Composições para tratar o cancro
NZ615430A (en) Method for on-demand contraception
WO2006010097A3 (fr) Compositions a liberation prolongee contenant des modulateurs des recepteurs du progesterone
NO20045217L (no) Anvendelse av tio-oxindolderivater for behandling av hormon relaterte tilstander
NO20062679L (no) Nye 17 β -hydroksysteroid-dehydrogenase-type 1-inhibitorer
HRP20110161T1 (hr) 18-metil-19-nor-androst-4-en-17,17-spiroeter (18-metil-19-nor-20-spiroks-4-en-3-oni) i farmaceutski pripravci koji ih sadrže
NZ589444A (en) NON-HORMONAL STEROID MODULATORS OF NF-Kappa B FOR TREATMENT OF DISEASE
CA2504697A1 (fr) Procedes pour traiter la migraine
WO2006066011A3 (fr) Composes et compositions utilises comme modulateurs de recepteurs steroidiens et d'activites du canal calcium
DE50308933D1 (de) Zusammensetzung, enthaltend ein androgenes 11-b-halogensteroid und ein gestagen sowie m nnliches kontrazeptivum auf basis dieser zusammensetzung
WO2005011617A3 (fr) Formes posologiques a administrer par voie transmuqueuse pour systemes de liberation de produit chimique steroide dirige sur le cerveau
CA2459033A1 (fr) Methodes d'inhibition de la deterioration cognitive chez des adultes atteints du syndrome de down
WO2005068487A3 (fr) Procedes de preparation de bromure de rocuronium et d'intermediaires de celui-ci
WO2007147134A3 (fr) Traitement de l'obésité à l'aide d'antagonistes des récepteurs muscariniques m1
BR0315746A (pt) Redução estereospecìfica de sapogen-3-onas
PT1635843E (pt) Terapia de substituição hormonal e de depressão compreendendo dienogest
WO2009140225A3 (fr) Stéroïdes glucocorticoïdes anti-inflammatoires et immunosuppresseurs
DK1848406T3 (da) Fast, penoral lægemiddelform til kontraception, der indeholder dienogest og ethynylestradiol
UA98938C2 (ru) Лечение психологических состояний с применением антагонистов мускариновых рецепторов м1

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application